位置:成果数据库 > 期刊 > 期刊详情页
无创性延迟肢体缺血预适应对抗大鼠脑缺血再灌注损伤的内皮机制
  • ISSN号:1001-5213
  • 期刊名称:《中国医院药学杂志》
  • 时间:0
  • 分类:R969[医药卫生—药理学;医药卫生—药学]
  • 作者机构:[1]天津医科大学总医院神经外科,天津300052, [2]天津医科大学神经病学研究所,天津300052, [3]天津医科大学总医院药剂科,天津300052, [4]天津医科大学药学院,天津300070, [5]天津医科大学基础医学院药理教研室,天津300070, [6]天津市第三医院,天津300250
  • 相关基金:国家自然资金(编号:81102447,81102446);中国博士后基金(编号:2013M541190)
中文摘要:

目的:研究无创性延迟肢体缺血预适应(noninvasive delayed limb ischemic preconditioning,NDLIP)对脑缺血再灌注大鼠内皮细胞分泌功能的影响并探讨其作用机制。方法:健康雄性Wistar大鼠随机分为假手术组(Sham)、脑缺血再灌损伤(ischemia-reperfusion injury, I/R)组、早期脑缺血预适应(early cerebral ischemic preconditioning,ECIP)组和NDLIP组,建立大鼠脑缺血再灌注模型,实施1 h缺血/24 h再灌注,ECIP组于缺血前左侧颈总动脉行3次5 min缺血/5 min再灌注,NDLIP组于缺血前3天每天左后肢实施3次5 min缺血/5 min再灌注。TTC染色法测定脑梗死面积,分别在缺血前及再灌注24 h后测定血清内皮素(endothelin, ET-1)、一氧化氮(nitric oxide, NO)的含量及组织纤溶酶原激活物(tissue plasminogen activator, t-PA)、纤溶酶原激活物抑制剂(plasminogen activator inhibitor, PAI-1)的活力。结果:缺血前,与I/R组比较,ECIP组和NDLIP组血清NO浓度升高(P〈0.05),ET-1/NO比值降低(P〈0.05),再灌注后,与I/R组比较,ECIP组和NDLIP组梗死范围显著减小,血清ET-1降低(P〈0.01),NO增加(P〈0.01),ET-1/NO比值降低(P〈0.05),t-PA活力升高(P〈0.01),PAI-1活力降低(P〈0.01)。结论:NDLIP可能是通过调整内皮细胞分泌收缩与舒张、促凝与抗凝物质的平衡,起到抵抗脑缺血再灌注损伤的作用,并且其保护程度与ECIP相当。

英文摘要:

OBJECrlVE To investigate effects of noninvasive delayed limb ischemic preconditioning (NDLIP) on secretive functions of vascular endothelial cells in rats with cerebral ischemia-reperfusion injury. METHODS Healthy male Wistar rats were divided randomly into operation group, cerebral ischemia-reperfusion (I/R) group, early cerebral ischemic preconditioning (ECIP) group and noninvasive delayed limb ischemic preconditioning (NDLIP) group. The model of cerebral I/R was estab- lished by 1 h of occlusion of middle cerebral artery followed by 24 h of reperfusion. Rats in ECIP group were subjected to 3 cy- cles of 5 rain of ischemia and reperfusion on common carotid artery before 1 h of ischemia and 24 h of reperfusion. Rats in NDLIP group were subjected to 3 cycles of 5 min of ischemia and reperfusion on left hind limb for 3 days to induce NDLIP. On the forth day, 1 h of ischemia and 24 h of reperfusion was performed. Cerebral infarction size was determined 24 h after I/R by TTC staining. Contents of nitric oxide (NO), endothelin (ET-1), tissue plasminogen activator (t-PA) and plasminogen activa- tor inhibitor (PAI-1) were measured before ischemia and 24 h after reperfusion, respectively. RESULITS Under normal condi- tions, NDLIP increased NO concentration in serum, slanted the balance between ET-I and NO toward NO. After I/R injury, infarction sizes of ECIP and NDLIP group decreased. NDLIP decreased the disturbance of endothelial function, increased NO in serum, decreased ET-1 concentration and maintained the balance between ET-1 and NO to approach normal. NDLIP increased t-PA activities and decreased PAI-1 activities. CONCLUSION NDLIP can protect brain from ischemia-reperfusion injury, which may contribute to its action on regulating the balance between vascular dilatation and contraction, procoagulant and anti- coagulant substances secreted by vascular endothelial cells. The protective effects of NDLIP were equivalent to those of ECIP.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国医院药学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中国药学会
  • 主编:陈华庭
  • 地址:武汉市汉口胜利街155号
  • 邮编:430014
  • 邮箱:pharmacy@vip.163.com
  • 电话:027-82836596
  • 国际标准刊号:ISSN:1001-5213
  • 国内统一刊号:ISSN:42-1204/R
  • 邮发代号:38-50
  • 获奖情况:
  • 曾获中国药学会优秀期刊二等奖,中国科协优秀期刊三等奖,湖北省优秀期刊奖
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:53772